kareayam
2021-08-16
Comment like , stonk! Hodl
3 High-Flying Stocks That May Fall 53% to 84%, According to Wall Street<blockquote>据华尔街称，3只飞涨的股票可能下跌53%至84%</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":839319838,"tweetId":"839319838","gmtCreate":1629121922024,"gmtModify":1631888803219,"author":{"id":3574924540403487,"idStr":"3574924540403487","authorId":3574924540403487,"authorIdStr":"3574924540403487","name":"kareayam","avatar":"https://static.tigerbbs.com/76c77978f4b287e714563b2757b7a227","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Comment like , stonk! Hodl</p></body></html>","htmlText":"<html><head></head><body><p>Comment like , stonk! Hodl</p></body></html>","text":"Comment like , stonk! Hodl","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/839319838","repostId":1137437693,"repostType":2,"repost":{"id":"1137437693","kind":"news","pubTimestamp":1629116844,"share":"https://www.laohu8.com/m/news/1137437693?lang=zh_CN&edition=full","pubTime":"2021-08-16 20:27","market":"us","language":"en","title":"3 High-Flying Stocks That May Fall 53% to 84%, According to Wall Street<blockquote>据华尔街称，3只飞涨的股票可能下跌53%至84%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1137437693","media":"Motley Fool","summary":"Analysts expect these soaring stocks to come crashing back to Earth.\n\nKey Points\n\nThe pandemic and/o","content":"<p> Analysts expect these soaring stocks to come crashing back to Earth. <b>Key Points</b></p><p><blockquote>分析师预计这些飙升的股票将会重挫。<b>要点</b></blockquote></p><p> <ul> <li>The pandemic and/or short squeezes have treated these three companies very well in 2021.</li> <li>Though Wall Street's price targets can often be taken with a grain of salt, these are likely on point.</li> </ul> It's a great time to be an investor. In the close to 17 months since the widely followed <b><a href=\"https://laohu8.com/S/.SPX\">S&P 500</a></b> bottomed out during the coronavirus crash in March 2020, the index has doubled in value. Time and again, patience begets profits on Wall Street.</p><p><blockquote><ul><li>2021年，疫情和/或轧空对这三家公司的待遇非常好。</li><li>尽管华尔街的价格目标通常可以持保留态度，但这些目标可能是正确的。</li></ul>现在是成为投资者的好时机。在近17个月的时间里，广受关注<b><a href=\"https://laohu8.com/S/.SPX\">标普500</a></b>该指数在2020年3月冠状病毒崩溃期间触底，现已翻了一番。耐心一次又一次地在华尔街带来利润。</blockquote></p><p> However, it's also common knowledge that not every stock is going to be a winner. According to Wall Street analysts and investment firms, there are three high-flying stocks that could lose anywhere from 53% to 84% of their value over the coming year, based on the consensus price target for each company.</p><p><blockquote>然而，众所周知，并非每只股票都会成为赢家。据华尔街分析师和投资公司称，根据每家公司的共识目标价，有三只飞涨的股票在未来一年可能会损失53%至84%的价值。</blockquote></p><p> <b>Moderna: Implied downside of 53%</b></p><p><blockquote><b>Moderna：隐含下跌53%</b></blockquote></p><p> First up is skyrocketing biotech stock <b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b>, which has gained almost 1,900% since the beginning of 2020. Even after pulling back more than 20% from its intraday high last week, Moderna's share price would have to fall by another 53% just to hit the consensus price target of $184.92.</p><p><blockquote>首先是飙升的生物科技股<b><a href=\"https://laohu8.com/S/MRNA\">莫德纳公司。</a></b>，自2020年初以来已上涨近1,900%。即使在从上周盘中高点回调超过20%后，Moderna的股价仍必须再下跌53%才能达到184.92美元的一致目标价。</blockquote></p><p> As you can probably guess, the reason Moderna has ascended to the heavens is the success of its emergency-use authorized (EUA) coronavirus disease 2019 (COVID-19) vaccine, mRNA-1273. In clinical trials, Moderna's vaccine candidate led to a vaccine efficacy (VE) of about 94%. With the exception of the<b> <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>/</b><b>BioNTech</b> vaccine, which presented with a 95% VE, no other EUA vaccines have come close on the efficacy front.</p><p><blockquote>正如您可能猜到的那样，Moderna升天的原因是其紧急使用授权(EUA)冠状病毒疾病2019(COVID-19)疫苗mRNA-1273的成功。在临床试验中，Moderna的候选疫苗的疫苗效力（VE）约为94%。除了<b> <a href=\"https://laohu8.com/S/PFE\">辉瑞</a>/</b><b>BioNTech</b>该疫苗的VE为95%，在功效方面没有其他EUA疫苗接近。</blockquote></p><p> The rise of the COVID-19 delta variant has been another major boon for Moderna. The transmissibility of delta has lifted vaccination rates in a number of developed countries, and it encouraged the U.S. Food and Drug Administration toauthorize a booster shotfor those people with compromised immune systems.</p><p><blockquote>COVID-19德尔塔变异毒株的崛起是Moderna的另一大福音。delta的传播性提高了许多发达国家的疫苗接种率，并鼓励了美国。美国食品药品监督管理局将授权为那些免疫系统受损的人注射加强针。</blockquote></p><p> Ultimately, Moderna's skyrocketing share price appears to indicate that things could worsen before they get better on the COVID-19 front, and that booster shots will offer a beefier stream of revenue than once predicted.</p><p><blockquote>最终，Moderna飙升的股价似乎表明，在COVID-19局势好转之前，情况可能会变得更糟，而加强注射将提供比以前预测的更强劲的收入流。</blockquote></p><p> However, the issue with Moderna's valuation is twofold. <a href=\"https://laohu8.com/S/FFBC\">First</a>, competition for COVID-19 vaccinations is increasing, not decreasing. <b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> is a good bet to receive EUA within the coming months, and <b><a href=\"https://laohu8.com/S/JNJ\">Johnson & Johnson</a></b> shouldn't have any trouble ramping up production of its single-dose vaccine. We'reprobably looking at Moderna's peak revenue year in 2021.</p><p><blockquote>然而，Moderna的估值问题是双重的。<a href=\"https://laohu8.com/S/FFBC\">第一</a>，新冠疫苗接种的竞争正在加剧，而不是减少。<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>在未来几个月内收到EUA是一个不错的选择，并且<b><a href=\"https://laohu8.com/S/JNJ\">强生公司</a></b>提高单剂量疫苗的产量应该没有任何问题。我们可能会在2021年看到Moderna的收入高峰年。</blockquote></p><p> The other issue is mRNA-1273 is Moderna's only marketable drug. A $157 billion market cap based on a single therapy that may or may not have staying powersounds very risky.</p><p><blockquote>另一个问题是mRNA-1273是Moderna唯一上市的药物。基于单一疗法的1570亿美元市值可能会也可能不会持续下去，这听起来风险很大。</blockquote></p><p> <b>Dillard's: Implied downside of 55%</b></p><p><blockquote><b>Dillard's：隐含下跌55%</b></blockquote></p><p> The next high-flying stock might come as a bit of a surprise... department store chain <b><a href=\"https://laohu8.com/S/DDS\">Dillard's</a></b>. Shares of Dillard's hit an all-time closing high of $196 on Friday, Aug. 13, pushing its market cap north of $4 billion. But according to analysts, which have a consensus price target of $87.33 on the company, this department store could be hitting the clearance rack with a 55% haircut over the next year.</p><p><blockquote>下一只飞涨的股票可能会有点令人惊讶...百货连锁店<b><a href=\"https://laohu8.com/S/DDS\">迪拉德氏</a></b>8月13日星期五，迪拉德的股价创下196美元的历史收盘新高，使其市值突破40亿美元。但分析师对该公司的一致目标价为87.33美元，该百货商店明年可能会降价55%。</blockquote></p><p> If you're wondering why Dillard's stock is up 625% over the trailing year, itsoperating performance would be a good place to start. The company drastically cut costs in the wake of the pandemic, strongly pushed direct-to-consumer sales, and has tightly managed its inventory. Without these burdensome overhead costs, profits have absolutely skyrocketed over the past two quarters as pent-up demand encouraged consumers to get out of their homes and into retail stores.</p><p><blockquote>如果您想知道为什么Dillard的股价在过去一年中上涨了625%，那么其经营业绩将是一个很好的起点。该公司在疫情爆发后大幅削减成本，大力推动直接面向消费者的销售，并严格管理库存。如果没有这些繁重的管理费用，过去两个季度的利润绝对飙升，因为被压抑的需求鼓励消费者走出家门，进入零售店。</blockquote></p><p> Dillard's has done a good job of attempting to boost shareholder value, too. In the 26 weeks, ended July 31, the company repurchased about 1.4 million shares totaling $171 million. This may not sound like a lot, but it reduced the company's outstanding share count by more than 6%.</p><p><blockquote>迪拉德在提高股东价值方面也做得很好。在截至7月31日的26周内，该公司回购了约140万股股票，总计1.71亿美元。这听起来可能不多，但它使公司的流通股数量减少了6%以上。</blockquote></p><p> It's also worth pointing out that Dillard's has a relatively small tradable float, and it's been a fairly heavily short-sold stock. This combination made it the perfect target for a short squeeze.</p><p><blockquote>还值得指出的是，迪拉德的可交易流通量相对较小，而且是一只被大量卖空的股票。这种组合使其成为轧空的完美目标。</blockquote></p><p></p><p> Despite all these positives, it's important for investors to recognize that retail department stores are generally slow-growing and cyclical. Even though Dillard's year-over-year comparisons are lights-out impressive, its 26-week retail sales for 2021 are only 1% higher than its 26-week retail sales for the comparable period in 2019. Further, comparable-store sales are only 4% higher in 2021 compared to 2019. While gross margin is notably higher, this has more to do with cost-cutting than significant sales traction.</p><p><blockquote>尽管有这些积极因素，但投资者必须认识到零售百货商店通常增长缓慢且具有周期性。尽管迪拉德的同比比较令人印象深刻，但其2021年26周零售额仅比2019年同期26周零售额高出1%。此外，与2019年相比，2021年同店销售额仅增长4%。虽然毛利率明显较高，但这更多地与成本削减有关，而不是显着的销售吸引力。</blockquote></p><p> Though Dillard's might defy Wall Street for a bit longer than expected, history suggestsit has no chance to keep up this pace. More than likely, Wall Street's price target will eventually become a reality.</p><p><blockquote>尽管迪拉德反抗华尔街的时间可能会比预期的要长一些，但历史表明它没有机会跟上这一步伐。华尔街的价格目标很可能最终会成为现实。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a>: Implied downside of 84%</b></p><p><blockquote><b><a href=\"https://laohu8.com/S/AMC\">AMC院线</a>：隐含下行空间84%</b></blockquote></p><p> Sporting the most potential downside, according to Wall Street's consensus price target, is movie theater stock <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a></b>. Although it's one of the year's top-performing stocks, AMC would need to decline by 84% from its current share price to hit the consensus target of $5.25 a share.</p><p><blockquote>根据华尔街的一致目标价，最具潜在下行空间的是电影院股<b><a href=\"https://laohu8.com/S/AMC\">AMC院线</a></b>尽管AMC是今年表现最好的股票之一，但它需要从当前股价下跌84%才能达到每股5.25美元的共识目标。</blockquote></p><p> AMC received a huge boost in January, when the company was able to save itself from bankruptcy by issuing common stock and debt. Short-sellers who'd been betting on additional downside in the company were caught off-guard by AMC's capital raise, which effected a viciousshort squeeze.</p><p><blockquote>AMC在一月份获得了巨大的提振，当时该公司通过发行普通股和债务使自己免于破产。一直押注该公司进一步下跌的卖空者对AMC的融资感到措手不及，这导致了恶性轧空。</blockquote></p><p> Today, AMC's impassioned retail investors share the same goal -- i.e., to see another short squeeze take place. As of July 30, 85.85 million shares were held short, representing almost 17% of the float.</p><p><blockquote>如今，AMC热情的散户投资者有着相同的目标——即看到另一次轧空。截至7月30日，8585万股被空头持有，几乎占流通股的17%。</blockquote></p><p> The problem for AMC and its retail investors is that fundamentals always matter, and AMC's operating performance and balance sheet arenothing short of a horror movie. While having increased capacity in its theaters drove sequential quarterly sales higher in the second quarter, it doesn't excuse the fact that AMC has burned through $576.5 million in cash over the past six months or that it's a long way from being profitable.</p><p><blockquote>AMC及其散户投资者面临的问题是，基本面始终很重要，AMC的经营业绩和资产负债表简直就是一部恐怖电影。虽然影院容量的增加推动了第二季度销售额的环比增长，但这并不能原谅AMC在过去六个月中消耗了5.765亿美元现金的事实，也不能原谅它距离盈利还有很长的路要走的事实。</blockquote></p><p> The balance sheet is a bigger concern. AMC ended June with $5.5 billion in corporate borrowing and had an additional $420 million in deferred rent that needs to be paid. With the company effectively maxing out its share issuances, AMC will be forced to rely on its $1.81 billion in cash and $212 million revolving credit facility to make good on its rent obligations and pay off its debt. With its 2026 and 2027 bonds going for 58% and 62% of par value, the clear implication from bondholders isthere's concern AMC won't remain solvent.</p><p><blockquote>资产负债表是一个更大的问题。截至6月底，AMC的企业借款为55亿美元，另外还有4.2亿美元的递延租金需要支付。随着该公司的股票发行实际上达到最大限度，AMC将被迫依靠其18.1亿美元的现金和2.12亿美元的循环信贷额度来偿还租金义务和债务。由于其2026年和2027年债券的价格分别为面值的58%和62%，债券持有人明确表示担心AMC将无法保持偿付能力。</blockquote></p><p> The icing on the cake is we'vewitnessed theatrical exclusivity dwindle. For instance, AMC's agreement with <a href=\"https://laohu8.com/S/T\">AT&T Inc</a>'s Warner Bros. offers only a 45-day exclusivity window, which is down from the traditional 75-day to 90-day period of exclusivity prior to the pandemic.</p><p><blockquote>锦上添花的是我们已经见证了戏剧排他性的减少。例如，AMC与<a href=\"https://laohu8.com/S/T\">AT&T公司</a>华纳兄弟公司仅提供45天的独家窗口，比大流行前传统的75天独家期减少到90天。</blockquote></p><p> It may take longer than 12 months, but AMC does look to beheaded back to its February low.</p><p><blockquote>这可能需要超过12个月的时间，但AMC确实有望跌回2月份的低点。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High-Flying Stocks That May Fall 53% to 84%, According to Wall Street<blockquote>据华尔街称，3只飞涨的股票可能下跌53%至84%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High-Flying Stocks That May Fall 53% to 84%, According to Wall Street<blockquote>据华尔街称，3只飞涨的股票可能下跌53%至84%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-08-16 20:27</span>\n</p>\n</h4>\n</header>\n<article>\n<p> Analysts expect these soaring stocks to come crashing back to Earth. <b>Key Points</b></p><p><blockquote>分析师预计这些飙升的股票将会重挫。<b>要点</b></blockquote></p><p> <ul> <li>The pandemic and/or short squeezes have treated these three companies very well in 2021.</li> <li>Though Wall Street's price targets can often be taken with a grain of salt, these are likely on point.</li> </ul> It's a great time to be an investor. In the close to 17 months since the widely followed <b><a href=\"https://laohu8.com/S/.SPX\">S&P 500</a></b> bottomed out during the coronavirus crash in March 2020, the index has doubled in value. Time and again, patience begets profits on Wall Street.</p><p><blockquote><ul><li>2021年，疫情和/或轧空对这三家公司的待遇非常好。</li><li>尽管华尔街的价格目标通常可以持保留态度，但这些目标可能是正确的。</li></ul>现在是成为投资者的好时机。在近17个月的时间里，广受关注<b><a href=\"https://laohu8.com/S/.SPX\">标普500</a></b>该指数在2020年3月冠状病毒崩溃期间触底，现已翻了一番。耐心一次又一次地在华尔街带来利润。</blockquote></p><p> However, it's also common knowledge that not every stock is going to be a winner. According to Wall Street analysts and investment firms, there are three high-flying stocks that could lose anywhere from 53% to 84% of their value over the coming year, based on the consensus price target for each company.</p><p><blockquote>然而，众所周知，并非每只股票都会成为赢家。据华尔街分析师和投资公司称，根据每家公司的共识目标价，有三只飞涨的股票在未来一年可能会损失53%至84%的价值。</blockquote></p><p> <b>Moderna: Implied downside of 53%</b></p><p><blockquote><b>Moderna：隐含下跌53%</b></blockquote></p><p> First up is skyrocketing biotech stock <b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b>, which has gained almost 1,900% since the beginning of 2020. Even after pulling back more than 20% from its intraday high last week, Moderna's share price would have to fall by another 53% just to hit the consensus price target of $184.92.</p><p><blockquote>首先是飙升的生物科技股<b><a href=\"https://laohu8.com/S/MRNA\">莫德纳公司。</a></b>，自2020年初以来已上涨近1,900%。即使在从上周盘中高点回调超过20%后，Moderna的股价仍必须再下跌53%才能达到184.92美元的一致目标价。</blockquote></p><p> As you can probably guess, the reason Moderna has ascended to the heavens is the success of its emergency-use authorized (EUA) coronavirus disease 2019 (COVID-19) vaccine, mRNA-1273. In clinical trials, Moderna's vaccine candidate led to a vaccine efficacy (VE) of about 94%. With the exception of the<b> <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>/</b><b>BioNTech</b> vaccine, which presented with a 95% VE, no other EUA vaccines have come close on the efficacy front.</p><p><blockquote>正如您可能猜到的那样，Moderna升天的原因是其紧急使用授权(EUA)冠状病毒疾病2019(COVID-19)疫苗mRNA-1273的成功。在临床试验中，Moderna的候选疫苗的疫苗效力（VE）约为94%。除了<b> <a href=\"https://laohu8.com/S/PFE\">辉瑞</a>/</b><b>BioNTech</b>该疫苗的VE为95%，在功效方面没有其他EUA疫苗接近。</blockquote></p><p> The rise of the COVID-19 delta variant has been another major boon for Moderna. The transmissibility of delta has lifted vaccination rates in a number of developed countries, and it encouraged the U.S. Food and Drug Administration toauthorize a booster shotfor those people with compromised immune systems.</p><p><blockquote>COVID-19德尔塔变异毒株的崛起是Moderna的另一大福音。delta的传播性提高了许多发达国家的疫苗接种率，并鼓励了美国。美国食品药品监督管理局将授权为那些免疫系统受损的人注射加强针。</blockquote></p><p> Ultimately, Moderna's skyrocketing share price appears to indicate that things could worsen before they get better on the COVID-19 front, and that booster shots will offer a beefier stream of revenue than once predicted.</p><p><blockquote>最终，Moderna飙升的股价似乎表明，在COVID-19局势好转之前，情况可能会变得更糟，而加强注射将提供比以前预测的更强劲的收入流。</blockquote></p><p> However, the issue with Moderna's valuation is twofold. <a href=\"https://laohu8.com/S/FFBC\">First</a>, competition for COVID-19 vaccinations is increasing, not decreasing. <b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> is a good bet to receive EUA within the coming months, and <b><a href=\"https://laohu8.com/S/JNJ\">Johnson & Johnson</a></b> shouldn't have any trouble ramping up production of its single-dose vaccine. We'reprobably looking at Moderna's peak revenue year in 2021.</p><p><blockquote>然而，Moderna的估值问题是双重的。<a href=\"https://laohu8.com/S/FFBC\">第一</a>，新冠疫苗接种的竞争正在加剧，而不是减少。<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>在未来几个月内收到EUA是一个不错的选择，并且<b><a href=\"https://laohu8.com/S/JNJ\">强生公司</a></b>提高单剂量疫苗的产量应该没有任何问题。我们可能会在2021年看到Moderna的收入高峰年。</blockquote></p><p> The other issue is mRNA-1273 is Moderna's only marketable drug. A $157 billion market cap based on a single therapy that may or may not have staying powersounds very risky.</p><p><blockquote>另一个问题是mRNA-1273是Moderna唯一上市的药物。基于单一疗法的1570亿美元市值可能会也可能不会持续下去，这听起来风险很大。</blockquote></p><p> <b>Dillard's: Implied downside of 55%</b></p><p><blockquote><b>Dillard's：隐含下跌55%</b></blockquote></p><p> The next high-flying stock might come as a bit of a surprise... department store chain <b><a href=\"https://laohu8.com/S/DDS\">Dillard's</a></b>. Shares of Dillard's hit an all-time closing high of $196 on Friday, Aug. 13, pushing its market cap north of $4 billion. But according to analysts, which have a consensus price target of $87.33 on the company, this department store could be hitting the clearance rack with a 55% haircut over the next year.</p><p><blockquote>下一只飞涨的股票可能会有点令人惊讶...百货连锁店<b><a href=\"https://laohu8.com/S/DDS\">迪拉德氏</a></b>8月13日星期五，迪拉德的股价创下196美元的历史收盘新高，使其市值突破40亿美元。但分析师对该公司的一致目标价为87.33美元，该百货商店明年可能会降价55%。</blockquote></p><p> If you're wondering why Dillard's stock is up 625% over the trailing year, itsoperating performance would be a good place to start. The company drastically cut costs in the wake of the pandemic, strongly pushed direct-to-consumer sales, and has tightly managed its inventory. Without these burdensome overhead costs, profits have absolutely skyrocketed over the past two quarters as pent-up demand encouraged consumers to get out of their homes and into retail stores.</p><p><blockquote>如果您想知道为什么Dillard的股价在过去一年中上涨了625%，那么其经营业绩将是一个很好的起点。该公司在疫情爆发后大幅削减成本，大力推动直接面向消费者的销售，并严格管理库存。如果没有这些繁重的管理费用，过去两个季度的利润绝对飙升，因为被压抑的需求鼓励消费者走出家门，进入零售店。</blockquote></p><p> Dillard's has done a good job of attempting to boost shareholder value, too. In the 26 weeks, ended July 31, the company repurchased about 1.4 million shares totaling $171 million. This may not sound like a lot, but it reduced the company's outstanding share count by more than 6%.</p><p><blockquote>迪拉德在提高股东价值方面也做得很好。在截至7月31日的26周内，该公司回购了约140万股股票，总计1.71亿美元。这听起来可能不多，但它使公司的流通股数量减少了6%以上。</blockquote></p><p> It's also worth pointing out that Dillard's has a relatively small tradable float, and it's been a fairly heavily short-sold stock. This combination made it the perfect target for a short squeeze.</p><p><blockquote>还值得指出的是，迪拉德的可交易流通量相对较小，而且是一只被大量卖空的股票。这种组合使其成为轧空的完美目标。</blockquote></p><p></p><p> Despite all these positives, it's important for investors to recognize that retail department stores are generally slow-growing and cyclical. Even though Dillard's year-over-year comparisons are lights-out impressive, its 26-week retail sales for 2021 are only 1% higher than its 26-week retail sales for the comparable period in 2019. Further, comparable-store sales are only 4% higher in 2021 compared to 2019. While gross margin is notably higher, this has more to do with cost-cutting than significant sales traction.</p><p><blockquote>尽管有这些积极因素，但投资者必须认识到零售百货商店通常增长缓慢且具有周期性。尽管迪拉德的同比比较令人印象深刻，但其2021年26周零售额仅比2019年同期26周零售额高出1%。此外，与2019年相比，2021年同店销售额仅增长4%。虽然毛利率明显较高，但这更多地与成本削减有关，而不是显着的销售吸引力。</blockquote></p><p> Though Dillard's might defy Wall Street for a bit longer than expected, history suggestsit has no chance to keep up this pace. More than likely, Wall Street's price target will eventually become a reality.</p><p><blockquote>尽管迪拉德反抗华尔街的时间可能会比预期的要长一些，但历史表明它没有机会跟上这一步伐。华尔街的价格目标很可能最终会成为现实。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a>: Implied downside of 84%</b></p><p><blockquote><b><a href=\"https://laohu8.com/S/AMC\">AMC院线</a>：隐含下行空间84%</b></blockquote></p><p> Sporting the most potential downside, according to Wall Street's consensus price target, is movie theater stock <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a></b>. Although it's one of the year's top-performing stocks, AMC would need to decline by 84% from its current share price to hit the consensus target of $5.25 a share.</p><p><blockquote>根据华尔街的一致目标价，最具潜在下行空间的是电影院股<b><a href=\"https://laohu8.com/S/AMC\">AMC院线</a></b>尽管AMC是今年表现最好的股票之一，但它需要从当前股价下跌84%才能达到每股5.25美元的共识目标。</blockquote></p><p> AMC received a huge boost in January, when the company was able to save itself from bankruptcy by issuing common stock and debt. Short-sellers who'd been betting on additional downside in the company were caught off-guard by AMC's capital raise, which effected a viciousshort squeeze.</p><p><blockquote>AMC在一月份获得了巨大的提振，当时该公司通过发行普通股和债务使自己免于破产。一直押注该公司进一步下跌的卖空者对AMC的融资感到措手不及，这导致了恶性轧空。</blockquote></p><p> Today, AMC's impassioned retail investors share the same goal -- i.e., to see another short squeeze take place. As of July 30, 85.85 million shares were held short, representing almost 17% of the float.</p><p><blockquote>如今，AMC热情的散户投资者有着相同的目标——即看到另一次轧空。截至7月30日，8585万股被空头持有，几乎占流通股的17%。</blockquote></p><p> The problem for AMC and its retail investors is that fundamentals always matter, and AMC's operating performance and balance sheet arenothing short of a horror movie. While having increased capacity in its theaters drove sequential quarterly sales higher in the second quarter, it doesn't excuse the fact that AMC has burned through $576.5 million in cash over the past six months or that it's a long way from being profitable.</p><p><blockquote>AMC及其散户投资者面临的问题是，基本面始终很重要，AMC的经营业绩和资产负债表简直就是一部恐怖电影。虽然影院容量的增加推动了第二季度销售额的环比增长，但这并不能原谅AMC在过去六个月中消耗了5.765亿美元现金的事实，也不能原谅它距离盈利还有很长的路要走的事实。</blockquote></p><p> The balance sheet is a bigger concern. AMC ended June with $5.5 billion in corporate borrowing and had an additional $420 million in deferred rent that needs to be paid. With the company effectively maxing out its share issuances, AMC will be forced to rely on its $1.81 billion in cash and $212 million revolving credit facility to make good on its rent obligations and pay off its debt. With its 2026 and 2027 bonds going for 58% and 62% of par value, the clear implication from bondholders isthere's concern AMC won't remain solvent.</p><p><blockquote>资产负债表是一个更大的问题。截至6月底，AMC的企业借款为55亿美元，另外还有4.2亿美元的递延租金需要支付。随着该公司的股票发行实际上达到最大限度，AMC将被迫依靠其18.1亿美元的现金和2.12亿美元的循环信贷额度来偿还租金义务和债务。由于其2026年和2027年债券的价格分别为面值的58%和62%，债券持有人明确表示担心AMC将无法保持偿付能力。</blockquote></p><p> The icing on the cake is we'vewitnessed theatrical exclusivity dwindle. For instance, AMC's agreement with <a href=\"https://laohu8.com/S/T\">AT&T Inc</a>'s Warner Bros. offers only a 45-day exclusivity window, which is down from the traditional 75-day to 90-day period of exclusivity prior to the pandemic.</p><p><blockquote>锦上添花的是我们已经见证了戏剧排他性的减少。例如，AMC与<a href=\"https://laohu8.com/S/T\">AT&T公司</a>华纳兄弟公司仅提供45天的独家窗口，比大流行前传统的75天独家期减少到90天。</blockquote></p><p> It may take longer than 12 months, but AMC does look to beheaded back to its February low.</p><p><blockquote>这可能需要超过12个月的时间，但AMC确实有望跌回2月份的低点。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/08/16/3-high-flying-stocks-may-fall-53-to-84-wall-street/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","MRNA":"Moderna, Inc.","DDS":"狄乐百货","JNJ":"强生",".SPX":"S&P 500 Index"},"source_url":"https://www.fool.com/investing/2021/08/16/3-high-flying-stocks-may-fall-53-to-84-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137437693","content_text":"Analysts expect these soaring stocks to come crashing back to Earth.\n\nKey Points\n\nThe pandemic and/or short squeezes have treated these three companies very well in 2021.\nThough Wall Street's price targets can often be taken with a grain of salt, these are likely on point.\n\nIt's a great time to be an investor. In the close to 17 months since the widely followed S&P 500 bottomed out during the coronavirus crash in March 2020, the index has doubled in value. Time and again, patience begets profits on Wall Street.\nHowever, it's also common knowledge that not every stock is going to be a winner. According to Wall Street analysts and investment firms, there are three high-flying stocks that could lose anywhere from 53% to 84% of their value over the coming year, based on the consensus price target for each company.\nModerna: Implied downside of 53%\nFirst up is skyrocketing biotech stock Moderna, Inc., which has gained almost 1,900% since the beginning of 2020. Even after pulling back more than 20% from its intraday high last week, Moderna's share price would have to fall by another 53% just to hit the consensus price target of $184.92.\nAs you can probably guess, the reason Moderna has ascended to the heavens is the success of its emergency-use authorized (EUA) coronavirus disease 2019 (COVID-19) vaccine, mRNA-1273. In clinical trials, Moderna's vaccine candidate led to a vaccine efficacy (VE) of about 94%. With the exception of the Pfizer/BioNTech vaccine, which presented with a 95% VE, no other EUA vaccines have come close on the efficacy front.\nThe rise of the COVID-19 delta variant has been another major boon for Moderna. The transmissibility of delta has lifted vaccination rates in a number of developed countries, and it encouraged the U.S. Food and Drug Administration toauthorize a booster shotfor those people with compromised immune systems.\nUltimately, Moderna's skyrocketing share price appears to indicate that things could worsen before they get better on the COVID-19 front, and that booster shots will offer a beefier stream of revenue than once predicted.\nHowever, the issue with Moderna's valuation is twofold. First, competition for COVID-19 vaccinations is increasing, not decreasing. Novavax is a good bet to receive EUA within the coming months, and Johnson & Johnson shouldn't have any trouble ramping up production of its single-dose vaccine. We'reprobably looking at Moderna's peak revenue year in 2021.\nThe other issue is mRNA-1273 is Moderna's only marketable drug. A $157 billion market cap based on a single therapy that may or may not have staying powersounds very risky.\nDillard's: Implied downside of 55%\nThe next high-flying stock might come as a bit of a surprise... department store chain Dillard's. Shares of Dillard's hit an all-time closing high of $196 on Friday, Aug. 13, pushing its market cap north of $4 billion. But according to analysts, which have a consensus price target of $87.33 on the company, this department store could be hitting the clearance rack with a 55% haircut over the next year.\nIf you're wondering why Dillard's stock is up 625% over the trailing year, itsoperating performance would be a good place to start. The company drastically cut costs in the wake of the pandemic, strongly pushed direct-to-consumer sales, and has tightly managed its inventory. Without these burdensome overhead costs, profits have absolutely skyrocketed over the past two quarters as pent-up demand encouraged consumers to get out of their homes and into retail stores.\nDillard's has done a good job of attempting to boost shareholder value, too. In the 26 weeks, ended July 31, the company repurchased about 1.4 million shares totaling $171 million. This may not sound like a lot, but it reduced the company's outstanding share count by more than 6%.\nIt's also worth pointing out that Dillard's has a relatively small tradable float, and it's been a fairly heavily short-sold stock. This combination made it the perfect target for a short squeeze.\nDespite all these positives, it's important for investors to recognize that retail department stores are generally slow-growing and cyclical. Even though Dillard's year-over-year comparisons are lights-out impressive, its 26-week retail sales for 2021 are only 1% higher than its 26-week retail sales for the comparable period in 2019. Further, comparable-store sales are only 4% higher in 2021 compared to 2019. While gross margin is notably higher, this has more to do with cost-cutting than significant sales traction.\nThough Dillard's might defy Wall Street for a bit longer than expected, history suggestsit has no chance to keep up this pace. More than likely, Wall Street's price target will eventually become a reality.\nAMC Entertainment: Implied downside of 84%\nSporting the most potential downside, according to Wall Street's consensus price target, is movie theater stock AMC Entertainment. Although it's one of the year's top-performing stocks, AMC would need to decline by 84% from its current share price to hit the consensus target of $5.25 a share.\nAMC received a huge boost in January, when the company was able to save itself from bankruptcy by issuing common stock and debt. Short-sellers who'd been betting on additional downside in the company were caught off-guard by AMC's capital raise, which effected a viciousshort squeeze.\nToday, AMC's impassioned retail investors share the same goal -- i.e., to see another short squeeze take place. As of July 30, 85.85 million shares were held short, representing almost 17% of the float.\nThe problem for AMC and its retail investors is that fundamentals always matter, and AMC's operating performance and balance sheet arenothing short of a horror movie. While having increased capacity in its theaters drove sequential quarterly sales higher in the second quarter, it doesn't excuse the fact that AMC has burned through $576.5 million in cash over the past six months or that it's a long way from being profitable.\nThe balance sheet is a bigger concern. AMC ended June with $5.5 billion in corporate borrowing and had an additional $420 million in deferred rent that needs to be paid. With the company effectively maxing out its share issuances, AMC will be forced to rely on its $1.81 billion in cash and $212 million revolving credit facility to make good on its rent obligations and pay off its debt. With its 2026 and 2027 bonds going for 58% and 62% of par value, the clear implication from bondholders isthere's concern AMC won't remain solvent.\nThe icing on the cake is we'vewitnessed theatrical exclusivity dwindle. For instance, AMC's agreement with AT&T Inc's Warner Bros. offers only a 45-day exclusivity window, which is down from the traditional 75-day to 90-day period of exclusivity prior to the pandemic.\nIt may take longer than 12 months, but AMC does look to beheaded back to its February low.","news_type":1,"symbols_score_info":{"JNJ":0.9,"AMC":0.9,"MRNA":0.9,".SPX":0.9,"DDS":0.9}},"isVote":1,"tweetType":1,"viewCount":1769,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":22,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/839319838"}
精彩评论